Identifiability of Biologicals: An Analysis Using EudraVigilance, the European Union's Database of Reports of Suspected Adverse Drug Reactions-Reference-Cited by-同舟云学术

Identifiability of Biologicals: An Analysis Using EudraVigilance, the European Union's Database of Reports of Suspected Adverse Drug Reactions

Author:

Correia Pinheiro Luis¹,Giezen Thijs J.²³⁴,Wolff‐Holz Elena⁴⁵,Weise Martina⁴⁶⁷,Laslop Andrea⁷⁸,Hidalgo‐Simon Ana¹

Affiliation:

1. European Medicines Agency (EMA) Amsterdam The Netherlands

2. Foundation Pharmacy for Hospitals in Haarlem Haarlem The Netherlands

3. Medicines Evaluation Board Utrecht The Netherlands

4. Biosimilar Medicinal Products Working Party (BMWP) European Medicines Agency Amsterdam The Netherlands

5. Bundesinstitut für Arzneimittel und Medizinprodukte Bonn Germany

6. Paul‐Ehrlich‐Institut Langen Germany

7. Committee for Medicinal Products for Human Use (CHMP) European Medicines Agency Amsterdam The Netherlands

8. Bundesamt für Sicherheit im Gesundheitswesen (BASG) Vienna Austria

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

Reference31 articles.

2. The top 20 drugs by global sales in 2019 [Internet];Blankenship K.;Fierce Pharma.,2020

4. European Medicines Agency.Biosimilars in the EU ‐ Information guide for healthcare professionals [Internet]. Amsterdam; 2019 .

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献